Sugarcane Aphid Update &
2015 Sugarcane Aphid Efficacy Trial – 14 DAT Counts
The
sugarcane aphid (SCA) is still having a heavy handed impact on the region. In the field it does seem we are performing better
in terms of knockdown and control with our treatments with several factors
playing key roles. The adjusted action
threshold seems to me a better fit for the High Plains and hits these prolific
aphids before they get their population built up too high. Producers, consultants, and applicators seem
to have a better understanding of the coverage needed via air or ground (air - 5
GPA minimum, 10 GPA preferred / ground – 15 GPA minimum, 20 GPA preferred) and
the change of adjuvants to something heavier, such as an MSO or silicone based
product, to better pull the treatment down lower into the canopy for control on
the lower portion of the plant.
On
August 19, 2015 we gathered our 14 DAT counts from our SCA Efficacy Trial. I have just now had the time to get the data
analyzed and this information released. This trial is an RBD and has 4
replications. Due to noted differences
in control between the upper leaves and lower leaves, we have calculated
differences in aphid numbers in terms of upper and lower leaves in addition to
total aphids averaged per leaf. Despite using
16.5 GPA, a standard rate of 0.25% NIS was utilized as an adjuvant, a standard
practice for all treatments applied in this area and what was recommended for
this research protocol. We did not get
good control on the lower leaves and no differences were found on those
leaves. This is one of the factors that lead us to recommend
an adjuvant change with company agreement for all commercial applications. For this trial, continuing to count the lower
leaves was proving pointless and quite time consuming. As a result we opted to only count the upper
leaf for the 14 DAT counts. This upper
leaf is actually the second leaf below the flag leaf.
Questions about rainfastness
Questions
about the rainfastness of these two leading products Transform and Sivanto are
common this season. All I can speak of
is this trial and what appears on the company label, which might not be
mentioned specifically. In addition,
there are questions about Transform’s performance in this trial.
Applications
for this trial were made on August 5, 2015.
Treatments began with the low rate of Sivanto at 9 am and continued down
the treatment list until Lorsban was applied at 11 am. We then gathered our pretreatment aphid
counts in the untreated border rows from each plot. Almost immediately following our leaving this
trial location, a heavy 0.75 inch rain began at 4:15 pm.
Dr.
Mike Lovelace, Dow, toured this trial with us as we made our 14 DAT
counts. Quoting from our discussion with
Dr. Lovelace, “This is a good trial and I can see the differences it is showing… This is the first instance with Transform I have
seen that control that was not a premium and I feel we have a stronger product
than this… The rates are off due to the
mistake in calibration, but all treatments are off the same… There must be some
outside reason for Transform’s lackluster performance here… The trial methodology is strong and there is
no research bias here but right now I am looking at the rainfall that occurred after
treatment on these plots as the culprit.”
Blayne
Reed
No comments:
Post a Comment